你即將離開本站

並前往https://www.europeanpharmaceuticalreview.com/news/175731/first-patient-receives-new-engineered-mrna-epigenetic/

First patient receives new engineered mRNA epigenetic

OTX-2002, a programmable epigenetic medicine is the first mRNA therapy to target MYC overexpression and could treat both cancer and ...

確定！ 回上一頁

查詢 「MRNA stock」的人也找了：